Table 4.
Encapsulated Drug | Conditions of Lyophilization Process | References | ||||
---|---|---|---|---|---|---|
Polymer | Freezing | Primary Drying |
Secondary Drying |
|||
PCL | Olmesartan Medoxomil |
−40 °C overnight | Different drying phases for about 48h * | [81] | ||
PCL | Vitamin E | −45 °C for 120 min | −20 °C for 480 min | +20 °C for 360 min | [82] | |
Chitosan + dextran sulphate | IutA protein from Escherichia coli | −80 °C | −40 to −20 °C for 35 h |
Gradually increase temperatures up to +20 °C | [83] | |
Chitosan | Docetaxel | Quickly frozen in liquid nitrogen | −35 °C for 60 h | 24 h in high vacuum | [84] | |
Hyaluronic acid | Docetaxel | −20 °C | −35 °C for 60 h 50 mTorr |
0 °C for 24 h | [85] | |
6-O-carboxymethyl chitosan | Ovalbumin | −50 °C for 30 min | −40 °C for 6 h | 20 °C for 4 h | [86] | |
Isobutylcyanoacrylate | Iodized oil | Liquid nitrogen | −90 °C for 48 h under 10 mPa * | [57] | ||
PCL | Fish oil | −30, −20 and −10 °C | −50 °C under 0.05 mbar * | [87] |
* No further information on the drying stages.